Undescended Testicle Market

Undescended Testicle Market Analysis

The Undescended Testicle Market size is estimated at USD 5.18 billion in 2025, and is expected to reach USD 7.33 billion by 2030, at a CAGR of 7.2% during the forecast period (2025-2030).

Factors such as an increase in preterm births, a family history of undescended testicles, and the rise in demand for diagnosis of undescended testicles (UDT) in young men are expected to drive the market's growth during the forecast period. For instance, according to the June 2023 update by the Pan American Health Organization, one preterm baby is born out of every ten babies born globally. Similarly, according to the May 2023 update by the National Library of Medicine, about 3% of full-term and 30% of premature male infants are born with undescended testicles. Thus, owing to the high occurrence of undescended testicles among neonates and preterm births, the demand for undescended testicle diagnosis and treatment is likely to rise, thereby driving the market's growth during the forecast period.

Furthermore, the success rate of the treatment options of UDT increases the adoption of the same, which fuels the market growth over the forecast period. For instance, according to the May 2023 update by Mayo Clinic, Orchiopexy, the leading surgical procedure for addressing a solitary undescended testicle, boasts an impressive success rate nearing 100%. Typically, post-surgery, the likelihood of fertility issues diminishes significantly for those with a single undescended testicle. However, for individuals with two undescended testicles, the surgical intervention yields a more modest enhancement. Hence, owing to the positive and acceptable results offered by the UDT treatment options, the demand for the studied market is likely to rise, thereby bolstering the market's growth during the forecast period.

Thus, owing to the advantages and benefits offered by the UDT treatment and the increase in UDT cases across the world, the studied market is expected to witness significant growth during the forecast period. However, the high cost of UDT treatment is likely to hinder the market's growth during the forecast period.

Undescended Testicle Market Trends

The Neonates Segment is Expected to Witness a Positive Growth During the Forecast Period

Undescended testes (UDTs) frequently occur in male neonates, particularly in premature births. Typically, a baby's testicles migrate from the abdomen, traverse the groin, and settle in the scrotum during pregnancy. In about 5% of boys, this migration halts prematurely, causing the testicle to be positioned along the pathway rather than settling in the scrotum, thus resulting in UDT. Factors such as an increase in preterm birth cases, a rise in congenital disabilities, and congenital complications are expected to fuel the segment's growth during the forecast period.

For instance, as per the April 2024 update from the Centers for Disease Control and Prevention (CDC), the preterm birth rate stood at 10.41% in 2023, showing little variation from the 10.38% rate recorded in 2022. From 2022 to 2023, the rates of early preterm births (those occurring before 34 completed weeks of gestation) and late preterm births (occurring between 34 to 36 weeks) remained largely stable. Hence, due to the emerging presence of preterm birth rates, the chance of the development of UDT is higher, thereby fueling the segment growth during the forecast period. Additionally, an increase in investments by government authorities to support neonatal care is expected to drive the segment's growth during the forecast period.

Furthermore, congenital complications among neonates are one of the main reasons for developing UDT. For instance, according to the article published in January 2024 in the World Journal of Advanced Research and Reviews, cryptorchidism, a prevalent congenital anomaly, is frequently overlooked during initial neonatal assessments. Doctors, while administering first neonatal care, often overlook a thorough examination of the baby's external genitalia. Besides, parents may either be oblivious to the issue or not give it due attention. This lack of awareness can postpone the identification and subsequent treatment of an undescended testis. Furthermore, it's noteworthy that cryptorchidism frequently coexists with other congenital disorders. Thus, such related complications among neonates make them more prone to developing UDT, thereby creating a demand for UDT treatment and diagnosis among neonates.

Thus, owing to the increase in preterm births and the rise in the adoption of UDT diagnosis and treatment options among neonates, the segment is expected to witness significant growth during the forecast period.

North America is Expected to Witness a Significant Growth During the Forecast Period

North America is expected to witness significant market growth owing to better healthcare infrastructure, the presence of major industry players, and increased demand for early diagnosis of congenital disabilities and genital complications among babies. For instance, according to data published in March 2022 by the Canadian Paediatric Society, preterm births account for approximately 8% of all live births in Canada, with 30% occurring before 34 weeks gestational age (GA) and 70% occurring between 34 and 36 weeks. Hence, the significant cases of preterm birth in the region create a demand for early diagnosis of UDT, which drives the market over the study period.

Furthermore, increasing government initiatives to support neonatal healthcare in the North American region is expected to drive the market growth over the forecast period. For example, the New York Health Department introduced the Perinatal and Infant Community Health Collaboratives (PICHC) Initiative for 2022-2027. This initiative aims to bolster community-driven efforts, enhancing the health and well-being of birthing individuals and their families. Additionally, New York State is actively working to elevate perinatal and infant health outcomes, specifically targeting high-need, low-income, Medicaid-eligible families. Key priority outcomes include reducing preterm birth, low birth weight issues, and infant and maternal mortality. Thus, owing to such initiatives to support neonatal care, UDT diagnosis and treatment options in North America are expected to be utilized, thereby driving the market's growth during the forecast period.

Therefore, due to the increase in preterm birth cases and the rise in government initiatives to support neonatal care, North America is expected to witness significant growth over the forecast period.

Undescended Testicle Industry Overview

The undescended testicle market is consolidated in nature due to the presence of a few companies operating globally and regionally. A few of the major companies in the market are Fujifilm Holdings Corporation, Bharat Biotech, Medtronic, GE HealthCare, and Stryker.

Undescended Testicle Market Leaders

Undescended Testicle Market News

• May 2024: USA Health Children’s & Women's Hospital's neonatal intensive care unit (NICU) was chosen to join The Tiny Baby Collaborative, an exclusive international research group. This initiative promotes cooperation and shared learning among hospitals that achieve exceptional outcomes for premature infants. The Tiny Baby Collaborative comprises around 25 hospitals from four countries. These hospitals consistently resuscitate children born at 22 to 23 weeks gestation and boast a history of successful outcomes. Additionally, neonatal staff from hospitals in Germany, Japan, and Sweden are active members of the group.
• June 2023: Wockhardt MamaCare unveiled 'Miracle,' a cutting-edge neonatal intensive care unit (NICU) and pediatric intensive care unit (PICU) dedicated to addressing health challenges in newborns and children. The NICU provides thorough care for infants facing structural abnormalities, infections, heart issues, and congenital disabilities.